Clinical Trial Update: Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients [Phase 3]

View source ↗

Summary

This Phase 3 trial investigates whether monosialoganglioside GM1 can prevent neurotoxicity caused by cisplatin-containing chemotherapy in non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Monosialoganglioside GM1 (GM1 monosialoganglioside)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN